Applied Clinical Trials
Applied Clinical Trials-09-01-2022
Volume: 31
Issue: 9
Applied Clinical Trials-08-01-2022
Volume: 31
Issue: 7/8
Applied Clinical Trials-06-01-2022
Volume: 31
Issue: 6
Applied Clinical Trials-05-01-2022
Volume: 31
Issue: 5
Applied Clinical Trials-04-01-2022
Volume: 31
Issue: 4
Applied Clinical Trials-03-01-2022
Volume: 31
Issue: 3
Applied Clinical Trials-02-01-2022
Volume: 31
Issue: 1/2
Applied Clinical Trials-12-01-2021
Volume: 30
Issue: 12
Applied Clinical Trials-11-01-2021
Volume: 30
Issue: 11
Applied Clinical Trials-10-01-2021
Volume: 30
Issue: 10
Applied Clinical Trials-09-01-2021
Volume: 30
Issue: 9
Applied Clinical Trials-08-01-2021
Volume: 30
Issue: 7/8
Applied Clinical Trials-06-01-2021
Volume: 30
Issue: 6
Applied Clinical Trials-05-01-2021
Volume: 30
Issue: 5
Applied Clinical Trials-04-01-2021
Volume: 30
Issue: 4
Applied Clinical Trials-03-01-2021
Volume: 30
Issue: 3
Applied Clinical Trials-02-01-2021
Volume: 30
Issue: 1/2
Applied Clinical Trials-12-01-2020
Volume: 29
Issue: 12
Applied Clinical Trials-11-01-2020
Volume: 29
Issue: 11
Applied Clinical Trials-10-01-2020
Volume: 29
Issue: 10
Applied Clinical Trials-09-01-2020
Volume: 29
Issue: 9
Applied Clinical Trials-08-01-2020
Volume: 29
Issue: 7/8
Applied Clinical Trials-06-01-2020
Volume: 29
Issue: 6
Applied Clinical Trials-05-01-2020
Volume: 29
Issue: 5
Applied Clinical Trials-04-01-2020
Volume: 29
Issue: 4
Applied Clinical Trials-03-01-2020
Volume: 29
Issue: 3
Applied Clinical Trials-02-01-2020
Volume: 29
Issue: 2
Applied Clinical Trials-12-01-2019
Volume: 28
Issue: 12
Applied Clinical Trials-11-01-2019
Volume: 28
Issue: 11
Applied Clinical Trials-10-01-2019
Volume: 28
Issue: 10
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Beyond Patient Centricity: What Rare Disease Research Gets Right
2
FDA Reaffirms GCP Standards Amid Growing Concerns Over Foreign Clinical Trial Data
3
Fortrea to Acquire Worldwide Clinical Trials' Early Phase Services Division in $45 Million Deal
4
AI Moves Patient Recruitment from Trial Bottleneck to Competitive Edge: A 2026 Perspective
5